Idiopathic Inflammatory Myopathies (IIMs) are a group of rare, heterogeneous autoimmune disorders characterized by chronic muscle inflammation and progressive muscle weakness. They include conditions such as dermatomyositis, polymyositis, immune-mediated necrotizing myopathy, antisynthetase syndrome, and inclusion body myositis. Recent advances have improved understanding of disease-specific autoantibodies, enabling better classification and prognostication. Modern imaging techniques, muscle biopsy refinements, and biomarker discovery have enhanced diagnostic accuracy.
Treatment strategies now emphasize early diagnosis, individualized immunosuppressive therapy, and multidisciplinary care. Ongoing research continues to refine targeted therapies and improve long-term outcomes for patients with IIMs. In collaboration with the Women’s Health in Rheumatology Association and Bharati…
